HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

pinellic acid

structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - pinellic acid: 2

Experts

1.	Kiyohara, Hiroaki: 2 articles (03/2003 - 07/2002)
2.	Nagai, Takayuki: 2 articles (03/2003 - 07/2002)
3.	Shirahata, Tatsuya: 2 articles (03/2003 - 07/2002)
4.	Sunazuka, Toshiaki: 2 articles (03/2003 - 07/2002)
5.	Yamada, Haruki: 2 articles (03/2003 - 07/2002)
6.	Harigaya, Yoshihiko: 1 article (03/2003)
7.	Kuwajima, Isao: 1 article (03/2003)
8.	Omura, Satoshi: 1 article (03/2003)
9.	Yamamoto, Daisuke: 1 article (03/2003)
10.	Yoshida, Kiminari: 1 article (03/2003)

Related Diseases

1.

Human Influenza (Influenza)

07/01/2002 - "The results of this study suggest that pinellic acid may provide a safe and potent oral adjuvant for nasal influenza HA vaccine."
03/10/2003 - "Pinellic acid is a novel and potentially useful oral adjuvant when used in conjunction with intranasal inoculation of influenza HA vaccines. "
07/01/2002 - "Intranasal administration of pinellic acid (1 microg) with influenza HA vaccine (1 microg) slightly enhanced antiviral IgG Ab titers in bronchoalveolar wash and serum but not antiviral IgA Ab titers in nasal and bronchoalveolar washes. "
07/01/2002 - "Oral administration of pinellic acid (1 microg) to BALB/c mice given primary and secondary intranasal inoculations of influenza HA vaccine (1 microg) enhanced antiviral IgA antibody (Ab) titers 5.2- and 2.5-fold in nasal and bronchoalveolar washes, respectively, and antiviral IgG Ab titers 3-fold in bronchoalveolar wash and serum. "

Related Drugs and Biologics

1.	Vaccines
2.	Immunoglobulin G (IgG)
3.	Immunoglobulin A (IgA)
4.	Antiviral Agents (Antivirals)

Related Therapies and Procedures

1.	Oral Administration
2.	Intranasal Administration